Request Demo
Last update 08 Aug 2026
Insulin Degludec Biosimilar(Zhejiang Hisun Pharmaceutical)
Last update 08 Aug 2026
Overview
Basic Info
Drug Type Biosimilar, Peptide Hormone |
Synonyms insulin degludec biosimilar(Zhejiang Hisun Pharmaceutical), HS-631 |
Target |
Action agonists |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 4857
The sequence is quoted from: *****
Sequence Code 91440
The sequence is quoted from: *****
Related
1
Clinical Trials associated with Insulin Degludec Biosimilar(Zhejiang Hisun Pharmaceutical)CTR20202156
单中心、随机、开放、二周期、双交叉评估HS631与诺和达®单次皮下给药在健康受试者中的药代动力学、药效学及安全性的I期临床试验
[Translation] A single-center, randomized, open-label, two-period, double-crossover Phase I clinical trial to evaluate the pharmacokinetics, pharmacodynamics and safety of HS631 and Tresiba® in healthy subjects after a single subcutaneous administration
100 Clinical Results associated with Insulin Degludec Biosimilar(Zhejiang Hisun Pharmaceutical)
Login to view more data
100 Translational Medicine associated with Insulin Degludec Biosimilar(Zhejiang Hisun Pharmaceutical)
Login to view more data
100 Patents (Medical) associated with Insulin Degludec Biosimilar(Zhejiang Hisun Pharmaceutical)
Login to view more data
100 Deals associated with Insulin Degludec Biosimilar(Zhejiang Hisun Pharmaceutical)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 1 | China | 19 Nov 2020 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free